Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Rosiglitazone/metformin combination

Kiayias JA, Vlachou ED, Theodosopoulou E, Lakka-Papadodima E. Rosiglitazone in combination with glime-piride plus metformin in type 2 diabetic patients. Diabetes Care 2002 25(7) 1251-2. [Pg.471]

Fonseca, V., Biswas, N., and Salzman, A. (1999). Once Daily Rosiglitazone in Combination with Metformin Effectively Reduces Hyperglycemia in Patients with Type 2 Diabetes. (Abstract), Diabetes48, (Suppl. 1), A100. [Pg.211]

Poulsen MK, Henriksen JE, Hother-Nielsen O, et al. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients. Diabetes Care 2003 26(12) 3273-3279. [Pg.110]

Other combination options Metformin or a Sulfonylurea plus Acarbose/Miglitol, or Pioglitazone/ Rosiglitazone or Repaglinide (with metformin), or Insulin... [Pg.502]

Rosiglitazone is a thiazolidinedione that can be used in combination with metformin or a sulphonylurea such as gliclazide. Rosiglitazone should be administered with caution in patients with cardiovascular disease. [Pg.40]

Avandia (rosiglitazone) as with other thiazolidinediones is used either as monotherapy or in combination with either metformin or a sulphonylurea. A disadvantage of rosiglitazone is the risk of heart failure as a side-effect. This risk is increased when rosiglitazone is used in patients with cardiovascular disease and when used in combination with insulin. Blood-glucose control may deteriorate temporarily when a thiazolidinedione is substituted for an oral antidiabetic agent. [Pg.164]

Rosiglitazone also is indicated for use in combination with a sulfonylurea, metformin, or insulin when diet, exercise, and a single agent do not result in... [Pg.325]

Combination therapy - When rosiglitazone is added to existing therapy, the current dose of sulfonylurea, insulin, or metformin can be continued upon initiation of rosiglitazone therapy. [Pg.326]

Rosiglitazone - Reports of anemia were greater in patients treated with a combination of rosiglitazone and metformin compared with rosiglitazone monotherapy. Edema was reported with higher frequency in the rosiglitazone plus insulin combination trials. [Pg.331]

When switching from combination therapy of rosiglitazone plus metformin as separate tablets - Starting dose is the dose of rosiglitazone and metformin already being taken. [Pg.338]

Rosiglitazone is approved for use as monotherapy and in conjunction with metformin, though it is sometimes combined with a sulfonylurea or insulin. It is usually taken once or twice a day with or without food. Rosiglitazone may cause a modest increase in low-density lipoprotein and triglyceride concentrations, but it is unclear whether this effect has any clinical significance or persists in the long term. [Pg.774]

Dailey GE III, Noor MA, Park J-S, Brace S, Fiedorek FT. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes a randomised double-blind trial. Am J Med 2004 116 223-9. [Pg.379]

Glibenclamide 2.5 mg/day + metformin 500 mg/day in a combination tablet was increased to a maximum of 10 mg/day + 2000 mg/day in patients with type 2 diabetes, mean age 57 years and weight 93 kg 181 patients also took rosiglitazone and 184 took placebo for 24 weeks... [Pg.460]

An 84-year-old man took rosiglitazone 4 mg/day for 11 months in combination with metformin 1 g bd and... [Pg.466]

Fonseca V, Rosenstock J, Patwardhan R, Salzman A. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus a randomized controlled trial. JAMA 2000 283(13) 1695-702. [Pg.470]

Combination Studies with Rosiglitazone Plus Sulfonylurea, Metformin or Insulin... [Pg.200]

Rosiglitazone maleate is a thiazolidinedione that increases insulin sensitivity improves sensitivity to insulin in muscles, adipose tissue and inhibits hepatic gluconeogenesis. It is indicated in improving glycemic control of type 2 diabetes mellitus as monotherapy and as an adjunct to diet and exercise and in combination with metformin, insulin, or a sulfonylurea when diet, exercise, and a single agent does not result in adequate glycemic control in patients with type 2 diabetes mellitus. [Pg.629]

Avandia BRL 49653 Rosiglitazone. Antidiabetic safe if used in combination with metformin hydrochloride. Bristol-Myers Squibb... [Pg.545]

The US FDA has approved pioglitazone and rosiglitazone for use as monotherapy for type 2 diabetes or in combination with metformin, sulfonylureas, or insulin. [Pg.88]

Rosiglitazone has been studied in combination with acarbose, digoxin, metformin, nifedipine, ranitidine, warfarin, and oral contraceptives [67,72] There have been no clinically significant effects on the pharmacokinetics of any of these agents in combination with rosiglitazone. [Pg.94]

See other pages where Rosiglitazone/metformin combination is mentioned: [Pg.333]    [Pg.9]    [Pg.333]    [Pg.9]    [Pg.326]    [Pg.326]    [Pg.213]    [Pg.944]    [Pg.368]    [Pg.442]    [Pg.1006]    [Pg.201]    [Pg.202]    [Pg.264]    [Pg.1023]    [Pg.688]    [Pg.303]    [Pg.419]    [Pg.630]    [Pg.1054]    [Pg.44]    [Pg.89]    [Pg.103]    [Pg.103]   
See also in sourсe #XX -- [ Pg.5 ]



SEARCH



Metformin

Metformin combination

© 2024 chempedia.info